Federal prosecutors in California are opening a federal probe into Juul Labs; the FDA has approved the first vaccine for smallpox and monkeypox; an analysis from the Congressional Budget Office finds that an approach to address surprise medical bills backed by doctors would cost the government billions.
Amid a rise in the number of vaping-related illnesses and multiple states putting temporarily holds on vaping products, federal prosecutors in California are opening a federal probe into Juul Labs. According to The Wall Street Journal, the investigation is in its early stages and the focus of the probe is unclear. The Federal Trade Commission (FTC), FDA, and multiple state attorneys are also investigating the e-cigarette maker’s marketing practices. The focus of the FTC probe is centered around whether Juul used social media influences and other marketing practices in order to appear to minors and the FDA is conducting a more wide-range investigation, focusing on marketing and outreach, as well as nicotine levels of the refill pods.
The FDA has given the nod to the first live, nonreplicating vaccine to prevent smallpox and monkeypox. The Jynneos Smallpox and Monkeypox Vaccine received approval for the prevention of smallpox and monkeypox in adults aged 18 years or older who are determined to be at high risk for smallpox and monkeypox infection. The vaccine is also part of the Strategies National Stockpile, which is the country’s largest supply of potentially lifesaving treatments and medical supplies for use in a public health emergency severe enough to causes shortages of local supplies.
An approach to curbing surprise medical bills that is backed by doctors groups would increase the deficit by “double digit billions” of dollars, according to an analysis from the Congressional Budget Office. According to The Hill, the approach has the support of doctor and hospital groups that are lobbying hard against leading legislation, arguing it would lead to damaging cuts to their payments. However, the new analysis shows that their favored approach would come with a high price tag while the leading approach would save the government $20 billion over 10 years. The difference between the 2 approaches is regarding how much the insurer would pay a doctor once a patient is protected.
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More